2 growth stocks, Eli Lilly and Regeneron, show potential for strong summer returns and long-term growth.
2 growth stocks, Eli Lilly and Regeneron Pharmaceuticals, are expected to thrive during the summer and beyond, offering potential investors strong returns. These pharmaceutical giants have performed well in the ongoing bull market and have the capabilities to continue delivering outsized returns over the long term. Investors can consider adding these stocks to their portfolios for long-term growth.
July 27, 2024
4 Articles